Business

TGTX Stock Outperforms 95% of Stocks. Here’s Why.

Published

1 hour ago

on

Multiple sclerosis treatment biotech stock TG Therapeutics (TGTX) is Monday’s IBD 50 Growth Stocks To Watch selection. The stock is clawing back from a sharp drop earlier this month, and Wall Street is expecting to see explosive earnings growth in upcoming quarters. TG Therapeutics holds the No. 4 spot in the IBD 50 behind Travere Therapeutics (TVTX), Eton Pharmaceuticals (ETON) and…

Copyright ©2026 Investor’s Business Daily, LLC. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8

Related Topics:

You must be logged in to post a comment Login

Leave a Reply

Cancel reply

Trending

Exit mobile version